GM Q4 Earnings Preview After EV Write-Downs

GM Q4 earnings will test whether a $6.0B EV write-down and idling of two Ultium Cells plants reshape trading, cash flow and EPS expectations.

January 27, 2026·3 min read
View all news articles
Flat vector of a dimming car battery cell symbolizing GM Q4 earnings amid EV write-downs and Ultium idling.

KEY TAKEAWAYS

  • Q4 results will reveal if GM can absorb a $6.0B EV charge without weakening near-term profits.
  • Temporary idling of two Ultium Cells plants and 1,550 layoffs cuts near-term battery output and utilization.
  • Street consensus for Q4 adjusted EPS centers near $2.2 and revenue near $45.5B.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

General Motors will report fourth-quarter 2025 results for the period ended December 31, 2025, before the market opens on January 27, 2026. Investors will watch GM Q4 earnings for signs of how multibillion electric-vehicle (EV) write-downs and the temporary idling of two Ultium Cells battery plants are affecting profit expectations.

Earnings and Street Expectations

Wall Street expects adjusted earnings per share (EPS) between $2.18 and $2.26 and revenue ranging from $45.4 billion to $45.8 billion. Consensus net income stands near $1.8 billion. GM has exceeded EPS estimates every quarter over the past year, most recently surpassing expectations by 22.8% in the third quarter of 2025. The company’s 2025 price-to-earnings ratio of 7.74 contrasts with an industry figure of -143.4, a valuation metric analysts will consider when evaluating the quarter.

GM has not provided guidance for 2026. Management has said it may take about six months to assess natural EV demand after federal incentives expire, a timeline investors will factor into capital spending and production forecasts.

EV Restructuring and Plant Idling

In early January 2026, GM disclosed a multibillion-dollar EV-related write-down and recorded a $6 billion charge linked to reducing EV investments, canceling supplier contracts, and scaling back EV output at key factories. This write-down reflects a reassessment of planned capital spending and supply arrangements and is expected to weigh on reported profits for the quarter. Investors will monitor whether GM can absorb these costs without significantly weakening short-term cash flow or margins.

Also in January, GM temporarily idled two Ultium Cells battery plants in Warren, Ohio, and Spring Hill, Tennessee, for six months, placing 1,550 workers on temporary layoff. The idling reduces near-term battery production capacity and could affect suppliers and plant utilization. Together with the write-down, this pause raises questions about how quickly GM can realign production with demand without incurring additional costs.

In October 2025, GM shuttered its hydrogen fuel-cell development program to focus capital and research and development on batteries, charging technology, and electric vehicles. This strategic narrowing preceded the recent EV plan retrenchment and signals a tighter focus on technology spending.

GM’s Honda-GM Fuel Cell System Manufacturing LLC joint venture in Michigan, established in 2017 with an $85 million GM investment and production starting in January 2024, is scheduled to cease production before the end of 2026 due to weak demand. Honda plans to pursue independent fuel-cell development, ending the collaborative manufacturing pathway GM had supported.

GM has integrated the Electrify America charging network into its myChevrolet, myGMC, and myCadillac apps, providing access to more than 5,000 stations and over 250,000 public chargers. This expansion enhances charging availability for Chevrolet, GMC, and Cadillac EV owners, representing a customer-facing investment even as the company reduces certain internal EV manufacturing capacity.

Whether GM can absorb the restructuring costs and operational disruptions from plant idling while meeting profit expectations will likely shape trading and analyst reactions to the quarter’s results. The report will test management’s ability to balance near-term financial pressures with a strategic shift toward battery systems and charging infrastructure.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI employee arrested after a hidden device was discovered; company says models identified installer and found no data loss easing investor risk.

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital convertible notes proposal would raise $850 million and include a concurrent exchange, raising dilution concerns and pressuring shares.

Character.AI Bankruptcy Draws Disney Interest

Character.AI Bankruptcy Draws Disney Interest

Character.AI bankruptcy starts a Section 363 sale with Disney as stalking-horse and $20 million bid, compressing the auction and shaping recoveries.

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile downgrade after Piper Sandler cut its target, citing launch pace doubts and SpaceX competition, tightening trader positioning.

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia incident triggered precautionary coaster closures and state reviews, raising near-term operational risk to attendance and shares.

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 earnings raised guidance to a $101.2 billion sales midpoint while MedTech weakness may force traders to reprice device risk.